Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Prothena (GB:0Y3M)
LSE:0Y3M
Prothena (0Y3M) Share Price & Analysis
0 Followers
0Y3M Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.27 - $79.16
Previous Close$68.16
Volume25.00
Average Volume (3M)221.00
Market Cap
$3.64B
Enterprise Value$2.96B
Total Cash (Recent Filing)$686.20M
Total Debt (Recent Filing)$4.88M
Price to Earnings (P/E)-25.9
Beta-0.80
Next Earnings
Aug 08, 2023EPS Estimate
-$0.96Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.63
Shares Outstanding52,751,775
10 Day Avg. Volume0
30 Day Avg. Volume221
Standard Deviation0.21
R-Squared0.04
Alpha-0.00625
Financial Highlights & Ratios
Price to Book (P/B)5.77
Price to Sales (P/S)267.53
Price to Cash Flow (P/CF)-18.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue53.88
Enterprise Value/Gross Profit54.89
Enterprise Value/Ebitda-20.61
Forecast
1Y Price Target
$84.80Price Target Upside24.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Prothena News
0Y3M FAQ
What was Prothena’s price range in the past 12 months?
Prothena lowest share price was $25.27 and its highest was $79.16 in the past 12 months.
What is Prothena’s market cap?
Currently, no data Available
When is Prothena’s upcoming earnings report date?
Prothena’s upcoming earnings report date is Aug 08, 2023 which is in 64 days.
How were Prothena’s earnings last quarter?
Prothena released its earnings results on May 04, 2023. The company reported -$0.89 earnings per share for the quarter, missing the consensus estimate of -$0.871 by -$0.019.
Is Prothena overvalued?
According to Wall Street analysts Prothena’s price is currently Undervalued.
Does Prothena pay dividends?
Prothena does not currently pay dividends.
What is Prothena’s EPS estimate?
Prothena’s EPS estimate is -$0.96.
How many shares outstanding does Prothena have?
Prothena has 52,751,774 shares outstanding.
What happened to Prothena’s price movement after its last earnings report?
Prothena reported an EPS of -$0.89 in its last earnings report, missing expectations of -$0.871. Following the earnings report the stock price went up 14.364%.
Which hedge fund is a major shareholder of Prothena?
Among the largest hedge funds holding Prothena’s share is Maple Rock Capital Partners Inc.. It holds Prothena’s shares valued at 14M.
---
Prothena Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$84.80 (24.42% Upside)
$84.80 (24.42% Upside)
Blogger Sentiment
Bearish
GB:0Y3M Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $5.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
158.27%
12-Months-Change
Fundamentals
Return on Equity
-24.38%
Trailing 12-Months
Asset Growth
27.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Prothena
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
---
---